Spyre Therapeutics SYRE Analyst Rating Update On August 26, 2026, Wedbush maintained an "Outperform" rating for Spyre Therapeutics Inc (SYRE) while adjusting i...
Market Samachar is a news aggregator. This article was originally published by gurufocus.com. Tap the button above to read the full story on their site.